1 result(s) for Lorvotuzumab mertansine (IMGN901)
| PI Name | Protocol # | Title |
|---|---|---|
| Alan Sandler | IRB00007952 | A Phase 1/2 Study to Assess the Safety and Efficacy of Lorvotuzumab Mertansine (IMGN901) in Combination with Carboplatin/Etoposide in Patients with Advanced Solid Tumors including Extensive Stage Small Cell Lung Cancer |
You may qualify for additional trials within our Phase 1 Program